Purpose of the Collaboration. 2.1 The purpose of the Collaboration is to:
Purpose of the Collaboration. 2.1 The Partners shall collaborate in order to deliver the Project as set out in Appendix 1.
Purpose of the Collaboration. The Parties enter into this Agreement in order for the Participant to provide data to WHO for use and dissemination as follows, and as more further detailed in the procedures and processes contained in the GBR website at the above-referenced address.
Purpose of the Collaboration. The purpose of the collaboration is for the Parties to collaborate in the Commercialization of the In-Line Products and Development and Commercialization of the Pipeline Products in the Collaboration Scope, all as described in more detail herein. It is the intent of the Parties that, regardless of the Party with the primary responsibility for execution of the Collaboration Activity or the Party holding the tie-breaking vote with respect to any matter, both Parties will actively collaborate in the conduct of the regulatory, Development, Commercialization, government affairs, distribution, compliance, financial oversight and audit activities hereunder within the Collaboration Territory. Notwithstanding the immediately preceding sentence, Amgen will have sole responsibility for manufacturing of the Products and, subject to the express terms of Article IX (Intellectual Property), prosecution, maintenance and enforcement of intellectual property. With respect to all activities and expenses reported under this Agreement, each Party covenants and agrees to reasonably, fairly and accurately reflect the underlying substance of such activities and expenses.
Purpose of the Collaboration. The purpose of the collaboration is for the Parties to collaborate in the development, manufacture and commercialization of the Products and for the Parties to share in certain costs and revenues related to the Products, all as described in more detail herein.
Purpose of the Collaboration. The purpose of the collaboration undertaken by the Parties under this Agreement is for the Parties to collaborate to perform certain activities with respect to the discovery, research, pre-clinical testing, development, clinical testing and manufacture of investigational Products in the Licensed Fields as described in more detail in this Agreement (the “Collaboration”). The Parties intend to capitalize on the strengths of each Party to accelerate Product development and recognize that Translate Bio has strengths in mRNA design, production and formulation and Sanofi has strengths in the immunology of infectious diseases.
Purpose of the Collaboration. The purpose of the collaboration is for the Parties to collaborate in the commercialization of Ivory in the Collaboration Scope and for the Parties to share in certain costs and revenues related to Ivory, all as described in more detail herein.
Purpose of the Collaboration. The purpose of the collaboration is to design, fabricate, and operate an instrument aboard the GLAST mission to study, with adequate efficiency and precision, gamma rays from space in order to enable the accomplishment of the proposed science program. The collaboration will undertake to carry out the science program, which is described in the proposal response to NASA AO 99-OSS-03 for the GLAST mission. Its primary goal is to accomplish a comprehensive study of the gamma-ray sky. This wide-range program provides an excellent opportunity to search for new phenomena.
Purpose of the Collaboration. 2.1 The Parties shall jointly co-operate subject to the scope and responsibilities set out below and subject to the terms of this Agreement.
Purpose of the Collaboration. 2.1 The aim of the Parties is to identify and validate Targets within the Target Field, carry out drug discovery and to advance drug development candidates for Novo. The Parties will collaborate on mining, nominating, and validating Targets, will decide on the molecular format of Candidate Targets and jointly conduct drug discovery, as further specified in the Research Plan. To this end, Evotec shall leverage its expertise, capabilities, and platform to design, implement and deliver (Candidate) Targets, compounds, leads, as well as biomarkers and patient stratification strategies. Novo EXECUTION VERSION 8 July 2020 may support the collaboration with its disease biology expertise, access to key opinion leaders as required, and preclinical and clinical development expertise. It is understood between the Parties that, if the Compound is a Small Molecule Compound, Evotec shall conduct the drug discovery activities. If the Compound is not a Small Molecule Compound, Novo will conduct the drug discovery activities.
